MarketCap
Facebook
X
Telegram
Biodesix Shares | BDSX
Annual Shares Biodesix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.55 M | 6.47 M | 82.1 M | 42.1 M | 27.4 M | 4.84 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82.1 M | 4.84 M | 28.4 M |
Quarterly Shares Biodesix
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.3 M | 9.66 M | 7.5 M | 147 M | 147 M | 7.27 M | 7.32 M | 127 M | 97.2 M | 96.2 M | 79.7 M | 78.5 M | 77.8 M | 77.6 M | 40.4 M | 39.2 M | 31.1 M | 30.8 M | 28.1 M | 27.7 M | 26.6 M | 26.6 M | 277 K | 275 K | 261 K | 255 K | 244 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 147 M | 244 K | 45.2 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 232.22 | 0.07 % | $ 25.8 B |  USA |
 |
Danaher Corporation
DHR
|
713 M | $ 221.21 | 3.34 % | $ 158 B | USA |
 |
DarioHealth Corp.
DRIO
|
3.98 M | $ 5.8 | 1.24 % | $ 23.1 M |  Israel |
 |
DexCom
DXCM
|
390 M | $ 86.9 | 1.8 % | $ 33.9 B | USA |
 |
Fulgent Genetics
FLGT
|
30.8 M | $ 22.45 | 4.52 % | $ 691 M | USA |
 |
Guardant Health
GH
|
125 M | $ 187.22 | 5.3 % | $ 23.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
78.4 M | $ 168.33 | 3.88 % | $ 13.2 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
80.4 M | $ 527.07 | 1.67 % | $ 42.4 B | USA |
 |
Illumina
ILMN
|
155 M | $ 293.69 | 7.56 % | $ 45.5 B | USA |
 |
IQVIA Holdings
IQV
|
172 M | $ 266.09 | 3.05 % | $ 45.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 308.65 | 0.05 % | $ 25.7 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 100.19 | 0.23 % | $ 6.76 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 620.51 | 3.51 % | $ 17.9 B | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 541.63 | 3.73 % | $ 31.8 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.58 | 0.88 % | $ 424 M | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 6.31 | 4.13 % | $ 4.97 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 19.13 | 3.57 % | $ 2.45 B | USA |
 |
Neogen Corporation
NEOG
|
218 M | $ 13.01 | 7.08 % | $ 2.83 B | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 20.78 | 2.11 % | $ 465 M | USA |
 |
Natera
NTRA
|
137 M | $ 425.64 | 3.73 % | $ 58.2 B | USA |
 |
OPKO Health
OPK
|
751 M | $ 1.57 | 0.64 % | $ 1.18 B | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 2.87 | 12.99 % | $ 861 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 23.91 | 0.04 % | $ 22.7 B |  Niderland |
 |
Precipio
PRPO
|
1.61 M | $ 24.0 | 3.76 % | $ 38.5 M | USA |
 |
Personalis
PSNL
|
89.2 M | $ 16.4 | 0.74 % | $ 1.46 B | USA |
 |
Quidel Corporation
QDEL
|
42.1 M | $ 12.14 | 12.72 % | $ 511 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | $ 45.79 | 2.34 % | $ 9.95 B | Niderland |
 |
RadNet
RDNT
|
75.2 M | $ 70.63 | 1.0 % | $ 5.31 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 10.31 | 4.35 % | $ 430 M | USA |
 |
Sotera Health Company
SHC
|
284 M | $ 18.55 | 1.81 % | $ 5.27 B | USA |
 |
Neuronetics
STIM
|
66 M | $ 2.2 | 1.85 % | $ 145 M | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 676.76 | 3.35 % | $ 255 B | USA |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 205.0 | 8.66 % | $ 12.3 B | USA |
 |
VolitionRx Limited
VNRX
|
126 M | $ 0.23 | 0.35 % | $ 28.9 M |  Singapore |
 |
Waters Corporation
WAT
|
59.5 M | $ 440.12 | 3.51 % | $ 26.2 B | USA |
 |
Exagen
XGN
|
21.6 M | $ 8.46 | 3.55 % | $ 182 M | USA |
 |
Syneos Health
SYNH
|
103 M | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Renalytix AI plc
RNLX
|
108 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Psychemedics Corporation
PMD
|
5.87 M | - | -1.84 % | $ 15.3 M | USA |
 |
T2 Biosystems
TTOO
|
2.61 M | - | -39.35 % | $ 313 K | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Meridian Bioscience
VIVO
|
43.6 M | - | - | $ 1.49 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Quotient Limited
QTNT
|
102 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Brainsway Ltd.
BWAY
|
34 M | $ 12.23 | 1.35 % | $ 415 M | Israel |